Shanghai Pharmaceuticals Holding Co., Ltd (OTCMKTS:SHPMF) Short Interest Up 40.0% in November

Shanghai Pharmaceuticals Holding Co., Ltd (OTCMKTS:SHPMFGet Free Report) saw a large growth in short interest in November. As of November 30th, there was short interest totalling 3,676,300 shares, a growth of 40.0% from the November 15th total of 2,625,500 shares. Based on an average trading volume of 1,400 shares, the days-to-cover ratio is presently 2,625.9 days.

Shanghai Pharmaceuticals Stock Performance

Shares of Shanghai Pharmaceuticals stock remained flat at $1.27 during trading on Friday. The firm’s 50 day simple moving average is $1.58 and its 200 day simple moving average is $1.45. Shanghai Pharmaceuticals has a 1-year low of $0.99 and a 1-year high of $1.95.

Shanghai Pharmaceuticals Company Profile

(Get Free Report)

Shanghai Pharmaceuticals Holding Co, Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer’s, and inflammatory bowel diseases.

Featured Stories

Receive News & Ratings for Shanghai Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shanghai Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.